LLY
HealthcareEli Lilly and Company
Drug Manufacturers - General
$934.34+9.77%
Key events (≥5% daily moves)
Up dayDown day
About This Company
Eli Lilly and Company is a global pharmaceutical company that discovers, develops, and sells medicines for a variety of health conditions. They are well-known for their treatments for diabetes, including popular insulin products and other medications. The company also develops important drugs for cancer, autoimmune diseases like arthritis, and neurological disorders. Essentially, Eli Lilly creates and sells innovative medicines to help people worldwide manage complex illnesses.
https://www.lilly.comKey Statistics
Open$898.78
Day High$945.50
Day Low$896.80
Prev. Close$851.21
52-Week High—
52-Week Low—
Market Cap$882.78B
Volume7.01M
Avg. Volume—
P/E Ratio—
EPS—
Beta0.50
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
47,000
Country
US
IPO Date
1972-06-01
Exchange
NYSE
52-Week Range
—
52W Low
$934.34
Current
—
52W High
Catalysts & Risks
Catalysts
- ▲Continued strong growth and expanded indications for Mounjaro/Zepbound (tirzepatide) in diabetes and obesity markets, driving significant revenue upside.
- ▲Positive clinical trial results and regulatory approval for Donanemab, its Alzheimer's treatment, opening up a new blockbuster market.
- ▲Successful advancement and commercialization of other pipeline assets in immunology, oncology, and neuroscience, diversifying revenue streams.
- ▲Strategic acquisitions or partnerships that enhance its R&D capabilities or expand its market presence in key therapeutic areas.
Risks
- ▼Intensified competition in the diabetes and obesity markets from new GLP-1 agonists or biosimilars, potentially eroding market share or pricing power.
- ▼Failure or delays in the clinical development or regulatory approval of key pipeline drugs, particularly Donanemab, impacting future growth prospects.
- ▼Increased scrutiny and pressure on drug pricing from governments and payers, leading to lower reimbursement rates or policy changes.
- ▼Product liability issues, unexpected side effects, or manufacturing challenges affecting existing or new drugs, leading to recalls or reputational damage.
AI-generated · For informational use only